Non-myeloablative conditioning with allogeneic progenitor cell transplantation for relapsed Hodgkin's lymphoma: High response rate despite prior chemoresistance.

被引：0
|
作者：
Goldstein, SC
Luger, SM
Stadtmauer, E
Schuster, S
Tsai, D
Nasta, S
Loren, A
Perl, A
Orloff, G
Oliver, J
Sachs, R
Emerson, S
Porter, DL
机构：
[1] Univ Penn, Bone Marrow & Stem Cell Transplant Program, Ctr Canc, Philadelphia, PA 19104 USA
[2] Fairfax Prince William Hematol Oncol, Fairfax, VA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.2258.2258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2258
引用
收藏
页码：621A / 622A
页数：2
相关论文
共 50 条
  • [1] Myeloablative vs non-myeloablative conditioning with allogeneic stem cell transplantation for high risk now Hodgkin's lymphoma: Similar outcomes despite differences in disease risk
    Hewitt, M
    Porter, DL
    Hummel, K
    McAlee, A
    Phillips, J
    Stadtmauer, E
    Schuster, S
    Luger, S
    Nasta, S
    Tsai, D
    Loren, A
    Perl, A
    Emerson, S
    Goldstein, SC
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 27 - 28
  • [2] Outcomes of allogeneic hematopoietic stem cell transplantation (HCT) after non-myeloablative conditioning in relapsed, refractory, or transformed indolent non-hodgkin lymphoma (NHL).
    Rezvani, Andrew R.
    Sandmaier, Brenda M.
    Storer, Barry
    Maris, Michael
    Agura, Edward
    Maziarz, Richard
    Wade, James C.
    Chauncey, Thomas
    Forman, Stephen J.
    Niederwieser, Dietger W.
    Shizuru, Judith
    Langston, Amelia
    Pulsipher, Michael
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2006, 108 (11) : 891A - 891A
  • [3] Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
    Hovgaard, Doris
    Sengelov, Henrik
    Vindelov, Lars
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S197 - S197
  • [4] Non-myeloablative allogeneic stem cell transplantation in mantle cell lymphoma
    Le Gouill, S.
    Kroeger, N.
    Dhedin, N.
    Nagler, A.
    Bouabdallah, K.
    Yakoub-Agha, I.
    Bulabois, C-E
    Buzyn, A.
    Rio, B.
    Moles, M-P.
    Shimoni, A.
    Guillaume, T.
    Milpied, N.
    Leux, C.
    Harousseau, J-L.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S67 - S67
  • [5] Tandem Autologous/Non-Myeloablative Allogeneic Transplantation for High Risk Non-Hodgkin Lymphoma (NHL)
    Fakhri, Bita
    Cashen, Amanda
    Comer, Holly
    Abboud, Camille
    Westervelt, Peter
    DiPersio, John E.
    Stockerl-Goldstein, Keith
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S300 - S300
  • [6] Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen
    Ungkanont, A
    Mongkonsritrakoon, W
    Jootar, S
    Srichaikul, T
    BONE MARROW TRANSPLANTATION, 2000, 26 (12) : 1351 - 1354
  • [7] Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen
    A Ungkanont
    W Mongkonsritrakoon
    S Jootar
    T Srichaikul
    Bone Marrow Transplantation, 2000, 26 : 1351 - 1354
  • [8] MYELOABLATIVE DOSES OF BUSULFAN AND FLUDARABINE AS CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA
    Figueroa, J.
    Perkins, J.
    Anassetti, C.
    Tomblyn, M.
    Field, T.
    Fernandez, H.
    Ochoa, J.
    Perez, L.
    Alsina, M.
    Locke, F.
    Nishihori, T.
    Pidala, J.
    Ayala, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S297 - S297
  • [9] Outcomes of allogeneic hematopoietic cell transplantation (HCT) after non-myeloablative conditioning in relapsed diffuse large B-cell lymphoma (DLBCL)
    Rezvani, Andrew R.
    Norasetthada, L.
    Gooley, T.
    Sorror, Mohamed
    Forman, Stephen J.
    Agura, Edward
    Chauncey, T.
    Maziarz, Richard T.
    Maris, Michael
    Shizuru, J.
    Bruno, B.
    Wade, James C.
    Lange, T.
    Yeager, Andrew
    Sandmaier, Brenda M.
    Storb, Rainer F.
    Maloney, David G.
    BLOOD, 2007, 110 (11) : 892A - 892A
  • [10] Non-myeloablative allogeneic ifematopoietic transplantation in relapsed/primary refractory follicular lymphoma.
    Fabre, C
    Recher, C
    Huynh, A
    Rigal-Huguet, F
    Abbal, M
    Dastugue, N
    Al Saati, T
    Brousset, P
    Attal, M
    BLOOD, 2004, 104 (11) : 635A - 635A
12345